High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer.

Kennedy, M J; Beveridge, R A; Rowley, S D; Gordon, G B; Abeloff, M D; Davidson, N E

Kennedy, M J; Beveridge, R A; Rowley, S D; Gordon, G B; Abeloff, M D; Davidson, N E.

Affiliation

Kennedy MJ; Johns Hopkins Oncology Center, Baltimore, MD 21205.

J Natl Cancer Inst ; 83(13): 920-6, 1991 Jul 03.

Article in En | MEDLINE | ID: mdl-1906111

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Bone Marrow Transplantation; Breast Neoplasms/drug therapy; Adult; Antineoplastic Combined Chemotherapy Protocols/toxicity; Breast Neoplasms/secondary; Breast Neoplasms/surgery; Cyclophosphamide/administration & dosage; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Middle Aged; Thiotepa/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Bone Marrow Transplantation Type of study: Guideline Limits: Adult / Female / Humans / Middle aged Language: En Journal: J Natl Cancer Inst Year: 1991 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links